AIM To investigate and compare the effects of tocotrienol and omeprazole on gastric growth factors in rats exposed to water-immersion restraint stress(WIRS).METHODS Twenty-eight male Wistar rats were randomly assigned...AIM To investigate and compare the effects of tocotrienol and omeprazole on gastric growth factors in rats exposed to water-immersion restraint stress(WIRS).METHODS Twenty-eight male Wistar rats were randomly assigned to four groups of seven rats. The two control groups were administered vitamin-free palm oil(vehicle) and the two treatment groups were given omeprazole(20 mg/kg) or tocotrienol(60 mg/kg) by oral gavage. After 28 d of treatment, rats from one control group and both treated groups were subjected to WIRS one time for 3.5 h. Gastric lesions were measured and gastric tissues were obtained to measure vascular endothelial growth factor(VEGF), epidermal growth factor(EGF), basic fibroblast growth factor(b FGF), and transforming growth factor-alpha(TGF-α) m RNA expression. RESULTS Rats exposed to WIRS for 3.5 h demonstrated the presence of considerable ulcers in the form of gastric erosion. The lesion index in the stressed control(S) group was increased(P < 0.001) compared to the tocotrienol treated and omeprazole treated groups. Stress led to a decrease in gastric VEGF(P < 0.001), b FGF(P < 0.001) and TGF-α(P < 0.001) m RNA levels and caused an increase in EGF m RNA(P < 0.001) that was statistically significant compared to the nonstressed control group. Although both treatment agents exerted similar ulcer reducing ability, only treatment with tocotrienol led to increased expression of VEGF(P = 0.008), b FGF(P = 0.001) and TGF-α(P = 0.002) m RNA.CONCLUSION Tocotrienol provides gastroprotective effects in WIRSinduced ulcers. Compared to omeprazole, tocotrienol exerts a similar protective effect, albeit through multiple mechanisms of protection, particularly through up-regulation of growth factors that assist in repair of gastric tissue injuries.展开更多
Tocotrienol(T3),the unsaturated form of vitamin E,has gained global attention due to its potent anticancer effects against a wide range of cancers.Found abundantly in palm oil[1],T3was reported to exhibit their anti-c...Tocotrienol(T3),the unsaturated form of vitamin E,has gained global attention due to its potent anticancer effects against a wide range of cancers.Found abundantly in palm oil[1],T3was reported to exhibit their anti-cancer properties via various pathways including anti-proliferative,anti-angiogenesis,antiinflammatory,apoptosis and improvement of immunological function[2].However,the lack of tumor specificity and rapid body clearance have restricted the clinical applications of T3[3].展开更多
Vesicular delivery systems have gainedmuch attention as pharmaceutical entities since their discovery.Niosomes occupy the general structure of bilayer vesicles,having a hydrophilic core shielded from one or multiple h...Vesicular delivery systems have gainedmuch attention as pharmaceutical entities since their discovery.Niosomes occupy the general structure of bilayer vesicles,having a hydrophilic core shielded from one or multiple hydrophobic lipid bilayer.This unique structure enables them to both accommodate oilsoluble compounds as well as to encapsulate water-soluble drugs[1].The anticancer effects of tocotrienol were first discovered in the early 1990s when Nesaretnam et al.reported that palm oil stripped of vitamin E-promoted tumorigenesis in rats[2].展开更多
The changes in content of fatty acids were studied every three months along the storage’s period, after adding an equal concentration (200 mg/Kg) of the natural antioxidant Tocotrienols (α-, β-, γ- and δ-T3) and ...The changes in content of fatty acids were studied every three months along the storage’s period, after adding an equal concentration (200 mg/Kg) of the natural antioxidant Tocotrienols (α-, β-, γ- and δ-T3) and of the synthetic one (BHT, BHA, AP) to four samples of different vegetable oils (sunflower oil, soybean oil, corn oil and olive oil). Then the oxidized and non-oxidized FAMEs were calculated to determine the antioxidant activity (AOA). The results showed that there was difference in AOA depending on the antioxidant of used. Tocotrienols were relatively weak compared with the synthetic antioxidant in all different types of oil. The AOA for each antioxidant was differed in different oil types. It was the most in the sunflower oil compared with the rest different oil types, while it was the lower for corn oil for all antioxidant. The AOA for BHA was the highest for different oil types compared with other antioxidants, and the δ-T3 had the lowest, while the rest anti-oxidants were in the following order: (BHA, BHT, AP, α-T3, β-T3, γ-T3, δ-T3).展开更多
Tocotrienols are found in a variety of natural sources,like rice bran,annatto seeds and palm oil,and have been shown to have several health-promoting properties,particularly against chronic diseases such as cancer.The...Tocotrienols are found in a variety of natural sources,like rice bran,annatto seeds and palm oil,and have been shown to have several health-promoting properties,particularly against chronic diseases such as cancer.The incidence of cancer is rapidly increasing around the world,not only a result of continued aging and population growth,but also due to the adoption of aspects of the Western lifestyle,such as high-fat diets and low-physical activity.The literature provides strong evidence that tocotrienols are able to inhibit the growth of various cancers,including breast,lung,ovarian,prostate,liver,brain,colon,myeloma and pancreatic cancers.These findings,along with the reported safety profile of tocotrienols in healthy human volunteers,encourage further research into these compounds’potential use in cancer prevention and treatment.The current review provided detailed information about the molecular mechanisms of action of different tocotrienol isoforms in various cancer models and evaluated the potential therapeutic effects of different vitamin E analogues on important cancer hallmarks,such as cellular proliferation,apoptosis,angiogenesis and metastasis.MEDLINE/PubMed and Scopus databases were used to identify recently published articles that investigated the anticancer effects of vitamin E derivatives in various types of cancer in vitro and in vivo along with clinical evidence of adjuvant chemopreventive benefits.Following an overview of pre-clinical studies,we describe several completed and ongoing clinical trials that are paving the way for the successful implementation of tocotrienols in cancer chemotherapy.展开更多
Objective:Tocotrienols(T3s)have been hypothesized to have greater antioxidant capacity than tocopherols(Ts)due to differences in biokinetics that affect their absorption and function.The present trial compares the ant...Objective:Tocotrienols(T3s)have been hypothesized to have greater antioxidant capacity than tocopherols(Ts)due to differences in biokinetics that affect their absorption and function.The present trial compares the antioxidant effectiveness following postprandial challenge of two different doses ofα-T or palm T3-rich fraction(TRF)treatments and evaluates their dose-response effects on antioxidant status.Methods:Ten healthy volunteers were given four different doses of vitamin E formulations(268 mgα-T,537 mgα-T,263 mg TRF or 526 mg TRF)in a cross-over postprandial trial.Blood was sampled at 0,2,4,5,6 and 8 hours after meal consumption and plasma antioxidant status including total glutathione,superoxide dismutase,malondialdehyde(MDA),ferric reducing antioxidant potential and trolox-equivalent antioxidant capacity,was analyzed.Results:Supplementation with the different doses of eitherα-T or TRF did not significantly improve overall antioxidant status.There was no significant difference in overall antioxidant status among treatments at the different doses compared.However,a significant dose-response effect was observed for plasma MDA throughout the 8-hour postprandial period.MDA was significantly lower after the 537 mgα-T treatment,compared to the 268 mgα-T treatment;it was also lower after the 526 mg TRF treatment compared to the 263 mg TRF treatment(P<0.05).Conclusion:T3 andα-T demonstrated similar antioxidant capacity,despite markedly lower levels of T3 in blood and lipoproteins,compared toα-T.展开更多
基金Supported by Universiti Kebangsaan Malaysia Research Fund,No.UKM-DLP-066-2011 and No.FF-032-2012
文摘AIM To investigate and compare the effects of tocotrienol and omeprazole on gastric growth factors in rats exposed to water-immersion restraint stress(WIRS).METHODS Twenty-eight male Wistar rats were randomly assigned to four groups of seven rats. The two control groups were administered vitamin-free palm oil(vehicle) and the two treatment groups were given omeprazole(20 mg/kg) or tocotrienol(60 mg/kg) by oral gavage. After 28 d of treatment, rats from one control group and both treated groups were subjected to WIRS one time for 3.5 h. Gastric lesions were measured and gastric tissues were obtained to measure vascular endothelial growth factor(VEGF), epidermal growth factor(EGF), basic fibroblast growth factor(b FGF), and transforming growth factor-alpha(TGF-α) m RNA expression. RESULTS Rats exposed to WIRS for 3.5 h demonstrated the presence of considerable ulcers in the form of gastric erosion. The lesion index in the stressed control(S) group was increased(P < 0.001) compared to the tocotrienol treated and omeprazole treated groups. Stress led to a decrease in gastric VEGF(P < 0.001), b FGF(P < 0.001) and TGF-α(P < 0.001) m RNA levels and caused an increase in EGF m RNA(P < 0.001) that was statistically significant compared to the nonstressed control group. Although both treatment agents exerted similar ulcer reducing ability, only treatment with tocotrienol led to increased expression of VEGF(P = 0.008), b FGF(P = 0.001) and TGF-α(P = 0.002) m RNA.CONCLUSION Tocotrienol provides gastroprotective effects in WIRSinduced ulcers. Compared to omeprazole, tocotrienol exerts a similar protective effect, albeit through multiple mechanisms of protection, particularly through up-regulation of growth factors that assist in repair of gastric tissue injuries.
文摘Tocotrienol(T3),the unsaturated form of vitamin E,has gained global attention due to its potent anticancer effects against a wide range of cancers.Found abundantly in palm oil[1],T3was reported to exhibit their anti-cancer properties via various pathways including anti-proliferative,anti-angiogenesis,antiinflammatory,apoptosis and improvement of immunological function[2].However,the lack of tumor specificity and rapid body clearance have restricted the clinical applications of T3[3].
文摘Vesicular delivery systems have gainedmuch attention as pharmaceutical entities since their discovery.Niosomes occupy the general structure of bilayer vesicles,having a hydrophilic core shielded from one or multiple hydrophobic lipid bilayer.This unique structure enables them to both accommodate oilsoluble compounds as well as to encapsulate water-soluble drugs[1].The anticancer effects of tocotrienol were first discovered in the early 1990s when Nesaretnam et al.reported that palm oil stripped of vitamin E-promoted tumorigenesis in rats[2].
文摘The changes in content of fatty acids were studied every three months along the storage’s period, after adding an equal concentration (200 mg/Kg) of the natural antioxidant Tocotrienols (α-, β-, γ- and δ-T3) and of the synthetic one (BHT, BHA, AP) to four samples of different vegetable oils (sunflower oil, soybean oil, corn oil and olive oil). Then the oxidized and non-oxidized FAMEs were calculated to determine the antioxidant activity (AOA). The results showed that there was difference in AOA depending on the antioxidant of used. Tocotrienols were relatively weak compared with the synthetic antioxidant in all different types of oil. The AOA for each antioxidant was differed in different oil types. It was the most in the sunflower oil compared with the rest different oil types, while it was the lower for corn oil for all antioxidant. The AOA for BHA was the highest for different oil types compared with other antioxidants, and the δ-T3 had the lowest, while the rest anti-oxidants were in the following order: (BHA, BHT, AP, α-T3, β-T3, γ-T3, δ-T3).
文摘Tocotrienols are found in a variety of natural sources,like rice bran,annatto seeds and palm oil,and have been shown to have several health-promoting properties,particularly against chronic diseases such as cancer.The incidence of cancer is rapidly increasing around the world,not only a result of continued aging and population growth,but also due to the adoption of aspects of the Western lifestyle,such as high-fat diets and low-physical activity.The literature provides strong evidence that tocotrienols are able to inhibit the growth of various cancers,including breast,lung,ovarian,prostate,liver,brain,colon,myeloma and pancreatic cancers.These findings,along with the reported safety profile of tocotrienols in healthy human volunteers,encourage further research into these compounds’potential use in cancer prevention and treatment.The current review provided detailed information about the molecular mechanisms of action of different tocotrienol isoforms in various cancer models and evaluated the potential therapeutic effects of different vitamin E analogues on important cancer hallmarks,such as cellular proliferation,apoptosis,angiogenesis and metastasis.MEDLINE/PubMed and Scopus databases were used to identify recently published articles that investigated the anticancer effects of vitamin E derivatives in various types of cancer in vitro and in vivo along with clinical evidence of adjuvant chemopreventive benefits.Following an overview of pre-clinical studies,we describe several completed and ongoing clinical trials that are paving the way for the successful implementation of tocotrienols in cancer chemotherapy.
基金fully funded by the Malaysian Palm Oil Board(MPOB).
文摘Objective:Tocotrienols(T3s)have been hypothesized to have greater antioxidant capacity than tocopherols(Ts)due to differences in biokinetics that affect their absorption and function.The present trial compares the antioxidant effectiveness following postprandial challenge of two different doses ofα-T or palm T3-rich fraction(TRF)treatments and evaluates their dose-response effects on antioxidant status.Methods:Ten healthy volunteers were given four different doses of vitamin E formulations(268 mgα-T,537 mgα-T,263 mg TRF or 526 mg TRF)in a cross-over postprandial trial.Blood was sampled at 0,2,4,5,6 and 8 hours after meal consumption and plasma antioxidant status including total glutathione,superoxide dismutase,malondialdehyde(MDA),ferric reducing antioxidant potential and trolox-equivalent antioxidant capacity,was analyzed.Results:Supplementation with the different doses of eitherα-T or TRF did not significantly improve overall antioxidant status.There was no significant difference in overall antioxidant status among treatments at the different doses compared.However,a significant dose-response effect was observed for plasma MDA throughout the 8-hour postprandial period.MDA was significantly lower after the 537 mgα-T treatment,compared to the 268 mgα-T treatment;it was also lower after the 526 mg TRF treatment compared to the 263 mg TRF treatment(P<0.05).Conclusion:T3 andα-T demonstrated similar antioxidant capacity,despite markedly lower levels of T3 in blood and lipoproteins,compared toα-T.